The contribution of functional neurosurgery to the understanding of the physiopathology of Parkinson’s disease
Juan Antonio Barcia, Fernando Alonso-Frech

Adv. Parkinson's Dis. Vol.2 No.3, July 22, 2013
DOI:10.4236/apd.2013.23017

Biological sources of L-DOPA: An alternative approach
Sushama A. Patil, Onkar A. Apine, Shripad N. Surwase, Jyoti P. Jadhav

Adv. Parkinson's Dis. Vol.2 No.3, July 19, 2013
DOI:10.4236/apd.2013.23016

Factors affecting early decline of executive function after subthalamic nucleus stimulation in Parkinson’s disease
Atsushi Umemura, Yuichi Oka, Rika Tsuboi, Sonoko Fujii, Yoko Shimizu, Kenji Okita, Noriyuki Matsukawa, Kazuo Yamada

Adv. Parkinson's Dis. Vol.2 No.3, July 19, 2013
DOI:10.4236/apd.2013.23015

Potential of a planarian model to study certain aspects of anti-Parkinsonism drugs
Robert B. Raffa, Jeff Danah, Christopher S. Tallarida, Carrie Zimmerman, Grace Gill, Steven J. Baron, Scott M. Rawls

Adv. Parkinson's Dis. Vol.2 No.3, July 19, 2013
DOI:10.4236/apd.2013.23014

Systems biology provides new tools for addressing Parkinson’s disease
Zhen Qi, Eberhard O. Voit

Adv. Parkinson's Dis. Vol.2 No.3, July 19, 2013
DOI:10.4236/apd.2013.23013